Qyuns Therapeutics Co., Ltd. Class H had a revenue of 103.24M in the quarter ending Jun 30, 2025, with 0.00%. This bring the company's revenue in the last twelve months to 320.36M, Decreased 33.72%. In the fiscal year ending Dec 31, 2024, Qyuns Therapeutics Co., Ltd. Class H had annual revenue of 158.79M with 976.49% growth.